During this time, ARO continues to provide services to those requiring radiation therapy.
You will be contacted directly with any changes to your appointments.
New patient referrals will be accepted but please note there may be some delays to starting treatments due to the current COVID-19 conditions. Please be aware of border requirements (here) if you need to travel across alert level boundaries for appointments.
Read more
-
ARO is open during Covid-19
Thu Aug. 26th 2021
As an essential medical service, ARO is open. ARO’s aim is to ensure patients receive radiation therapy treatment within a safe environment.
-
Covid-19 Update
Thu March 26th 2020
As an essential medical service, ARO would like to reassure patients and their support networks that ARO is open.
-
ARO becomes Sweet Louise sponsor
Thu July 25th 2019
ARO enters new sponsorship arrangement with Sweet Louise. Established in 2006, Sweet Louise was launched with the single minded vision of improving the quality of life for New Zealanders living with incurable breast cancer.
-
nib NZ Offers Members Genetic Testing to Help Treat Ovarian Cancer
Mon March 4th 2019
Women with ovarian cancer can now access genetic testing services in the private health system to help determine their best course of treatment, following a first-ever partnership between nib New Zealand and the New Zealand Family Cancer Service.
-
ARO 2008 - 2018 ten year anniversary video
Mon Nov. 26th 2018
New Zealand's first private radiation oncology centre turns 10.
-
Prostate Cancer Precise Detection and Staging Insight by Dr Benji Benjamin
Tue Oct. 10th 2017
PSMA is an enzyme found in abundance on the cell surface of prostate cancer cells. Until recently patients newly diagnosed with high risk prostate cancer or patients where the prostate cancer has returned or metastasised would generally undergo a range of scans such as CT, bone and MRI to detect and stage prostate cancer.
Ask us a question
Do you have something to ask that isn't answered here? You can either try our FAQs page, or send us your question below.